“I had the pleasure to closely interact with Jeroen over the last seven years. Jeroen has this rare ability to translate the science related to a business opportunity into pragmatic product development and commercial plans. I have been amazed by his ability to build strong network across and beyond the organization which has been a catalyst to generate our results. Without a doubt, Jeroen has the courage to put integrity first. Trusting him and partnering with him is certainly a recipe to generate positive impact. ”
Jeroen Van den Bossche, PhD
Ghent, Flemish Region, Belgium
4K followers
500+ connections
4K followers
500+ connections
About
As a Specialist Sales professional at KBC Securities, I leverage over 25 years of…
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Recommendations received
7 people have recommended Jeroen
Join now to viewOther similar profiles
Explore more posts
-
PolyPeptide Group
🚀 Capacity expansion for major Pharma's hormonal disorders and women's health portfolio We're proud to announce a capacity expansion at our Braine-l'Alleud site in Belgium, strategically backed by customer financing. This investment underscores our commitment to capturing growth in the dynamic global peptide market. 🔬 What this means: ✅ Advanced process equipment for highly complex peptides ✅ Strict environmental control capabilities for demanding modalities ✅ Multi-year commercial contract securing long-term partnership ✅ Enhanced end-to-end support from development to commercial supply "From early development to commercial supply, we've been in close collaboration with our client every step of the way," shares Stéphane Varray, our Chief Commercial Officer. "This investment demonstrates our strong partnership with our long-standing customer and our commitment to drive long-term growth." This expansion further solidifies PolyPeptide's position as a trusted CDMO partner for complex peptide therapeutics worldwide. 💪 #PeptideManufacturing #CDMO #LifeSciences #Partnerships #Growth #Innovation #BioPharma
6 Comments -
The Riverside Company
The Riverside Company is pleased to announce that A.forall, one of the portfolio companies of its affiliated European fund, has signed a definitive agreement to sell its Retail & Hospital (R&H) business unit to Abacus Medicine, a pharmaceutical company specialising in parallel import and distribution across Europe. The transaction is expected to close in the second half of the year. https://lnkd.in/eUeffMsu
2 Comments -
Labiotech.eu
Did you know that Belgium has a thriving biotech industry? 🇧🇪 In fact, the country is positioned as a key player in the global biotech landscape with its biotech clusters like BioVille, the Brussels South Charleroi BioPark, and the Ghent Bio-Energy Valley. 🤝🧬 Belgium has several biotechs specializing in cancer therapeutics, immunotherapies, and microbiome research, to name a few. 💊🏥 Read our latest article to find out about eight biotechs in Belgium doing promising therapeutic R&D in the clinic! 👇 https://lnkd.in/d6zRcy7h #belgiumbiotech #lifesciences #immunotherapy #therapeuticinnovation #europeanbiotech #healthinnovation Agomab Augustine Therapeutics Confo Therapeutics Galapagos Hyloris Pharmaceuticals Imcyse SA MRM Health Precirix
4 Comments
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More